tiprankstipranks
Trending News
More News >
Nascent Pharma Holdings (NASC)
OTHER OTC:NASC
US Market

Nascent Pharma Holdings (NASC) Revenue

Compare
28 Followers

Nascent Pharma Holdings Revenue

Nascent Pharma Holdings had a revenue of 15.27K in the quarter ending Sep 30, 2024, with -94.39%. This bring the company's revenue in the last twelve months to 1.03M, Increased -28.09%. In the fiscal year ending Dec 31, 2024, Nascent Pharma Holdings had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
1.03M
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
12
Market Cap
$1.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-2.16M-100.00%
Dec 31, 2023
2.16M-4.53M-67.76%
Dec 31, 2022
6.69M2.08M+45.22%
Dec 31, 2021
4.60M2.89M+169.28%
Mar 31, 2021
1.71M-595.83K-25.84%
Mar 31, 2020
2.31M1.64M+244.82%
Dec 31, 2018
668.60K545.86K+444.70%
Dec 31, 2017
122.75K